[go: up one dir, main page]

ES8504459A1 - Procedimiento para preparar factor de transferencia especifico a un virus determinado. - Google Patents

Procedimiento para preparar factor de transferencia especifico a un virus determinado.

Info

Publication number
ES8504459A1
ES8504459A1 ES524306A ES524306A ES8504459A1 ES 8504459 A1 ES8504459 A1 ES 8504459A1 ES 524306 A ES524306 A ES 524306A ES 524306 A ES524306 A ES 524306A ES 8504459 A1 ES8504459 A1 ES 8504459A1
Authority
ES
Spain
Prior art keywords
transfer factor
virus
viral infections
treating viral
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524306A
Other languages
English (en)
Other versions
ES524306A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO COM Inc
Original Assignee
BIO COM Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO COM Inc filed Critical BIO COM Inc
Publication of ES8504459A1 publication Critical patent/ES8504459A1/es
Publication of ES524306A0 publication Critical patent/ES524306A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR FACTOR DE TRANSFERENCIA ESPECIFICO A UN VIRUS DETERMINADO.CONSISTE EN INMUNIZAR UN MAMIFERO CON RESPECTO AL VIRUS Y OBTENER EL FACTOR DE TRANSFERENCIA ASI PRODUCIDO ESPECIFICO AL VIRUS DE CELULAS DE HIGADO DEL MAMIFERO INMUNIZADO, EN DONDE EL VIRUS ES UN HERPESVIRUS, ELEGIDO ENTRE VIRUS HERPES SIMPLES 1, VIRUS HERPES SIMPLES 2, CITOMEGALOVIRUS O VIRUS HERPES ZOSTER. EL FACTOR DE TRANSFERENCIA SE OBTIENE EN FORMA DE UNA FRACCION CELULAR QUE NO CONTIENE PRACTICAMENTE MOLECULAS CON UN PESO MOLECULAR SUPERIOR A 12.000.SE EMPLEA EN TERAPIA PARA EL TRATAMIENTO DE INFECCIONES CUTANEO-MUCOSALES.
ES524306A 1982-07-20 1983-07-20 Procedimiento para preparar factor de transferencia especifico a un virus determinado. Granted ES524306A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8220915 1982-07-20

Publications (2)

Publication Number Publication Date
ES8504459A1 true ES8504459A1 (es) 1985-05-01
ES524306A0 ES524306A0 (es) 1985-05-01

Family

ID=10531777

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524306A Granted ES524306A0 (es) 1982-07-20 1983-07-20 Procedimiento para preparar factor de transferencia especifico a un virus determinado.

Country Status (6)

Country Link
EP (1) EP0101200A3 (es)
JP (1) JPS5967226A (es)
AU (1) AU1696283A (es)
DK (1) DK332683A (es)
ES (1) ES524306A0 (es)
ZA (1) ZA835244B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment
WO1992000087A1 (en) * 1990-07-02 1992-01-09 National Jewish Center For Immunology And Respiratory Medicine Process for obtaining pure peptide transfer factor, transfer factor thus obtained and uses thereof
ATE158184T1 (de) * 1990-07-02 1997-10-15 Nat Jewish Ct Immun & Respirat Herstellung und verwendung von transfer-faktor
EP0537722A3 (en) * 1991-10-15 1994-07-13 Kremers Urban Co Porcane liver polypeptides for treating viral infections
DE69331322T3 (de) * 1992-07-17 2009-10-22 Merck & Co., Inc. Methode zur verhinderung von zoster und linderung der mit varicellea verbundenen postherpetischen neuralgie
JPH07299021A (ja) * 1994-05-09 1995-11-14 Koyo Autom Mach Co Ltd 容器類の洗浄装置
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
GB2341551A (en) * 1997-06-05 2000-03-22 Royal Free Hosp School Med Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder
GB2347742B (en) * 1997-06-05 2001-11-07 Royal Free Hosp School Med Pharmaceutical composition for RBD
CN1089608C (zh) * 1999-04-12 2002-08-28 中国人民解放军第四军医大学第一附属医院 抗呼吸道病毒转移因子生产工艺
GB9919179D0 (en) 1999-08-16 1999-10-20 Luk Getriebe Systeme Gmbh Transmission systems
CZ299296B6 (cs) * 2006-06-13 2008-06-11 Sevapharma A.S. Lécivo transfer faktor - zpusob výroby a použití

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener

Also Published As

Publication number Publication date
ZA835244B (en) 1985-02-27
DK332683D0 (da) 1983-07-19
DK332683A (da) 1984-01-21
AU1696283A (en) 1984-01-26
ES524306A0 (es) 1985-05-01
EP0101200A2 (en) 1984-02-22
JPS5967226A (ja) 1984-04-16
EP0101200A3 (en) 1985-03-06

Similar Documents

Publication Publication Date Title
ES8504459A1 (es) Procedimiento para preparar factor de transferencia especifico a un virus determinado.
DE69030880D1 (de) Zusammensetzung zur Stimulierung des Immunsystems
SE8300623L (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
ES8507567A1 (es) Metodo para estabilizar un concentrado de gamma globulina
EP0616535A4 (en) PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
TW259710B (es)
JPS5329908A (en) Immobilized haptoglobin preparation
ES436028A1 (es) Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.
DK0504191T3 (da) Præparat til behandling af HIV-infektioner
FI954127A0 (fi) Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
ES457602A1 (es) Procedimiento para la preparacion de un agente para la pro- filaxis y terapia de la gastroenteritis.
EP0156478A3 (en) Propagation of group ii avian adeno (aa) virus in avian cell culture and vaccine produced
JPS5639019A (en) Antiviral agent
ES8605576A1 (es) Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b
SU578966A1 (ru) Способ лечени сифилиса
SU1069818A1 (ru) Способ профилактики гриппа
AU2211592A (en) Method of treatment for latent virus infection
SU70583A1 (ru) Способ лечени микробных инфекций
JPS562918A (en) Preventive and remedy for infection of pig atrophic rhinitis
IL107818A0 (en) Method of treating viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vinyl substituted nucleoside analog
Talyzina About intravenous vaccine therapy for brucellosis in children

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108